Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Venkata

Showing results (41-50 of 162) with videos related to

Pageof 17
Sort By:
Expert Review of Cardiovascular Therapy|December 21, 2010
Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide triple combination for hypertensionC Venkata S Ram
Current Medical Research and Opinion|January 10, 2008
Angiotensin blockade with eprosartan: vascular and functional implicationsC Venkata S Ram
Journal of Clinical Hypertension (Greenwich, Conn.)|July 9, 2008
Beta-blockers in hypertension: truths and half-truthsC Venkata S Ram
Journal of Clinical Hypertension (Greenwich, Conn.)|May 4, 2010
Could baroreceptor activation therapy be the future for treating hypertension and other chronic cardiovascular conditions?C Venkata S Ram
Journal of Clinical Hypertension (Greenwich, Conn.)|March 27, 2014
Hypertension guidelines in need of guidanceC Venkata S Ram
European Heart Journal|March 4, 2023
'Normal' blood pressure is no longer a safe haven: take shelter under 'optimal' blood pressureC Venkata S Ram
Journal of Managed Care Pharmacy : JMCP|August 4, 2007
Need to revisit step therapy for ARBsC Venkata Ram, Thomas Giles
Current Hypertension Reports|July 16, 2002
Are angiotensin converting enzyme inhibitors and angiotensin receptor blockers becoming the treatment of choice in African-Americans?Andrew Fenves, C Venkata S Ram
Indian Heart Journal|November 12, 2013
Hypertension in children, not a "small" problemAnusha Uddaraju, C Venkata S Ram
Cardiology Clinics|July 18, 2002
Clinical pharmacology of antihypertensive drugsC Venkata S Ram, Andrew Fenves
Pageof 17

Showing results (41-50 of 162) with videos related to

Sort By:
Pageof 17
Expert Review of Cardiovascular Therapy|December 21, 2010
Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide triple combination for hypertensionC Venkata S Ram
Current Medical Research and Opinion|January 10, 2008
Angiotensin blockade with eprosartan: vascular and functional implicationsC Venkata S Ram
Journal of Clinical Hypertension (Greenwich, Conn.)|July 9, 2008
Beta-blockers in hypertension: truths and half-truthsC Venkata S Ram
Journal of Clinical Hypertension (Greenwich, Conn.)|May 4, 2010
Could baroreceptor activation therapy be the future for treating hypertension and other chronic cardiovascular conditions?C Venkata S Ram
Journal of Clinical Hypertension (Greenwich, Conn.)|March 27, 2014
Hypertension guidelines in need of guidanceC Venkata S Ram
European Heart Journal|March 4, 2023
'Normal' blood pressure is no longer a safe haven: take shelter under 'optimal' blood pressureC Venkata S Ram
Journal of Managed Care Pharmacy : JMCP|August 4, 2007
Need to revisit step therapy for ARBsC Venkata Ram, Thomas Giles
Current Hypertension Reports|July 16, 2002
Are angiotensin converting enzyme inhibitors and angiotensin receptor blockers becoming the treatment of choice in African-Americans?Andrew Fenves, C Venkata S Ram
Indian Heart Journal|November 12, 2013
Hypertension in children, not a "small" problemAnusha Uddaraju, C Venkata S Ram
Cardiology Clinics|July 18, 2002
Clinical pharmacology of antihypertensive drugsC Venkata S Ram, Andrew Fenves
Pageof 17